Cited by 683Histone Deacetylase Inhibitors ResearchAdvanced Proteomics Techniques and ApplicationsMass Spectrometry Techniques and Applications

The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.

Chemoproteomics profiling of HDAC inhibitors reveals selective targeting of HDAC complexes

Bantscheff, Marcus, Hopf, Carsten, Savitski, Mikhail M, Dittmann, Antje, Grandi, Paola, Michon, Anne-Marie, Schlegl, Judith, Abraham, Yann, Becher, Isabelle, Bergamini, Giovanna, Boesche, Markus, Delling, Manja, Dümpelfeld, Birgit, Eberhard, Dirk, Huthmacher, Carola, Mathieson, Toby, Poeckel, Daniel, Reader, Valérie, Strunk, Katja, Sweetman, Gavain, Kruse, Ulrich, Neubauer, Gitte, Ramsden, Nigel G, Drewes, Gerard·2011·Nature Biotechnology

DOI 10.1038/nbt.1759

Open this paper in CoChat — free account

Abstract

The development of selective histone deacetylase (HDAC) inhibitors with anti-cancer and anti-inflammatory properties remains challenging in large part owing to the difficulty of probing the interaction of small molecules with megadalton protein complexes. A combination of affinity capture and quantitative mass spectrometry revealed the selectivity with which 16 HDAC inhibitors target multiple HDAC complexes scaffolded by ELM-SANT domain subunits, including a novel mitotic deacetylase complex (MiDAC). Inhibitors clustered according to their target profiles with stronger binding of aminobenzamides to the HDAC NCoR complex than to the HDAC Sin3 complex. We identified several non-HDAC targets for hydroxamate inhibitors. HDAC inhibitors with distinct profiles have correspondingly different effects on downstream targets. We also identified the anti-inflammatory drug bufexamac as a class IIb (HDAC6, HDAC10) HDAC inhibitor. Our approach enables the discovery of novel targets and inhibitors and suggests that the selectivity of HDAC inhibitors should be evaluated in the context of HDAC complexes and not purified catalytic subunits.

Integrity signals

Registry

Crossref · 10.1038/nbt.1759

Cites

50 of 50 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Chromatin modifications and their function
Kouzarides, T. (2007) · Cell · doi:10.1016/j.cell.2007.02.005 · Cited by 10,883
Lysine acetylation targets protein complexes and co-regulates major cellular functions
Choudhary, C., Kumar, C., Gnad, F., Nielsen, M. L., Rehman, M., Walther, T. C., Olsen, J. V., & Mann, M. (2009) · Science · doi:10.1126/science.1175371 · Cited by 4,040
Anticancer activities of histone deacetylase inhibitors
Bolden, J. E., Peart, M. J., & Johnstone, R. W. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2133 · Cited by 2,919
Proteome survey reveals modularity of the yeast cell machinery
Gavin, A., Aloy, P., Grandi, P., Krause, R., Böesche, M., Marzioch, M., Rau, C., Jensen, L. J., Bastuck, S., Dümpelfeld, B., et al. (2006) · Nature · doi:10.1038/nature04532 · Cited by 2,570
Self-citation
Pvclust: an R package for assessing the uncertainty in hierarchical clustering
Suzuki, R., & Shimodaira, H. (2006) · Bioinformatics · doi:10.1093/bioinformatics/btl117 · Cited by 2,456
Regulation of cellular metabolism by protein lysine acetylation
Zhao, S., Xu, W., Jiang, W., Yu, W., Lin, Y., Zhang, T., Yao, J., Zhou, L., Zeng, Y., Li, H., et al. (2010) · Science · doi:10.1126/science.1179689 · Cited by 1,910
A Mammalian Histone Deacetylase Related to the Yeast Transcriptional Regulator Rpd3p
Taunton, J., Hassig, C. A., & Schreiber, S. L. (1996) · Science · doi:10.1126/science.272.5260.408 · Cited by 1,829
Parts per Million Mass Accuracy on an Orbitrap Mass Spectrometer via Lock Mass Injection into a C-trap
Olsen, J. V., de Godoy, L. M. F., Li, G., Maček, B., Mortensen, P., Pesch, R., Makarov, A., Lange, O., Horning, S. R., & Mann, M. (2005) · Molecular & Cellular Proteomics · doi:10.1074/mcp.t500030-mcp200 · Cited by 1,539
Molecular evolution of the histone deacetylase family: functional implications of phylogenetic analysis
Gregoretti, I., Lee, Y.-M., & Goodson, H. V. (2004) · Journal of Molecular Biology · doi:10.1016/j.jmb.2004.02.006 · Cited by 1,456
The Cell as a Collection of Protein Machines: Preparing the Next Generation of Molecular Biologists
Alberts, B. (1998) · Cell · doi:10.1016/s0092-8674(00)80922-8 · Cited by 1,411

Flagged first, then by citations

Show all 50 references

Sorted by citations

Items 301–400 of 683

Natural Products as Zinc‐Dependent Histone Deacetylase Inhibitors
Tan, S., & Liu, Z. (2015) · ChemMedChem · doi:10.1002/cmdc.201402460 · Cited by 31
Discovery of a Highly Selective Tankyrase Inhibitor Displaying Growth Inhibition Effects against a Diverse Range of Tumor Derived Cell Lines
Thomson, D. W., Wagner, A. J., Bantscheff, M., Benson, R. E., Dittus, L., Duempelfeld, B., Drewes, G., Krause, J., Moore, J. T., Mueller, K., et al. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00137 · Cited by 31
Self-citation
Distinct biochemical properties of the class I histone deacetylase complexes
Lee, K., Whedon, S. D., Wang, Z. A., & Cole, P. A. (2022) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2022.102179 · Cited by 33
Interrogating Substrate Selectivity and Composition of Endogenous Histone Deacetylase Complexes with Chemical Probes
Dose, A., Sindlinger, J., Bierlmeier, J., Bakirbas, A., Schulze‐Osthoff, K., Einsele‐Scholz, S., Hartl, M., Eßmann, F., Finkemeier, I., & Schwarzer, D. (2015) · Angewandte Chemie International Edition · doi:10.1002/anie.201508174 · Cited by 30
Biophysical Studies on Interactions and Assembly of Full-size E3 Ubiquitin Ligase
Bulatov, E., Martin, E. M., Chatterjee, S., Knebel, A., Shimamura, S., Konijnenberg, A., Johnson, C., Zinn, N., Grandi, P., Sobott, F., et al. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.616664 · Cited by 30
Self-citation
Hydroxyl Ketone-Based Histone Deacetylase Inhibitors To Gain Insight into Class I HDAC Selectivity versus That of HDAC6
Traore, M. D. M., Zwick, V., Simões‐Pires, C. A., Nurisso, A., Issa, M. E., Cuendet, M., Maynadier, M., Wein, S., Vial, H. J., Jamet, H., et al. (2017) · ACS Omega · doi:10.1021/acsomega.6b00481 · Cited by 30
MIER3 suppresses colorectal cancer progression by down-regulating Sp1, inhibiting epithelial-mesenchymal transition
Peng, M., Hu, Y., Song, W., Duan, S., Xu, Q., Ding, Y., Geng, J., & Zhou, J. (2017) · Scientific Reports · doi:10.1038/s41598-017-11374-y · Cited by 30
Valproic acid disrupts the oscillatory expression of core circadian rhythm transcription factors
Griggs, C. A., Malm, S. W., Jaime-Frias, R., & Smith, C. L. (2017) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2017.12.005 · Cited by 31
Pyrimethamine conjugated histone deacetylase inhibitors: Design, synthesis and evidence for triple negative breast cancer selective cytotoxicity
Wu, B., Fathi, S., Mortley, S., Mohiuddin, M., Jang, Y. C., & Oyelere, A. K. (2020) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2020.115345 · Cited by 30
Quantitative Proteomic Analysis Identifies Targets and Pathways of a 2-Aminobenzamide HDAC Inhibitor in Friedreich’s Ataxia Patient iPSC-Derived Neural Stem Cells
Shan, B., Xu, C., Zhang, Y., Xu, T., Gottesfeld, J. M., & Yates, J. R. (2014) · Journal of Proteome Research · doi:10.1021/pr500514r · Cited by 28
Overlapping and Divergent Actions of Structurally Distinct Histone Deacetylase Inhibitors in Cardiac Fibroblasts
Schuetze, K. B., Stratton, M. S., Blakeslee, W. W., Wempe, M. F., Wagner, F. F., Holson, E. B., Kuo, Y., Andrews, A. J., Gilbert, T. M., Hooker, J. M., et al. (2017) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.116.237701 · Cited by 29
Causes and Significance of Increased Compound Potency in Cellular or Physiological Contexts
Schwaid, A. G., & Cornella‐Taracido, I. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00762 · Cited by 29
Sunlight‐ or UVA‐Light‐Mediated Synthesis of Hydroxamic Acids from Carboxylic Acids
Mountanea, O. G., Mantzourani, C., Kokotou, M. G., Kokotos, C. G., & Kokotos, G. (2023) · European Journal of Organic Chemistry · doi:10.1002/ejoc.202300046 · Cited by 29
TORC1 and class I HDAC inhibitors synergize to suppress mature B cell neoplasms
Simmons, J. K., Patel, J. D., Michalowski, A. M., Zhang, S., Wei, B., Sullivan, P., Gamache, B., Felsenstein, K. M., Kuehl, W. M., Simpson, R. J., et al. (2013) · Molecular Oncology · doi:10.1016/j.molonc.2013.11.007 · Cited by 28
MIER2/PGC1A elicits sunitinib resistance via lipid metabolism in renal cell carcinoma
Wei, Z., Ye, Y., Liu, C., Wang, Q., Zhang, Y., Chen, K., Cheng, G., & Zhang, X. (2024) · Journal of Advanced Research · doi:10.1016/j.jare.2024.04.032 · Cited by 28
Class I Histone Deacetylase HDAC1 and WRN RECQ Helicase Contribute Additively to Protect Replication Forks upon Hydroxyurea-induced Arrest
Kehrli, K., Phelps, M., Lazarchuk, P., Chen, E. Y., Monnat, R., & Sidorova, J. M. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.708594 · Cited by 28
Targeting Transcription Factor Lysine Acetylation in Inflammatory Airway Diseases
van den Bosch, T., Kwiatkowski, M., Bischoff, R., & Dekker, F. J. (2017) · Epigenomics · doi:10.2217/epi-2017-0027 · Cited by 28
Inflammation‐mediated deacetylation of the ribonuclease 1 promoter via histone deacetylase 2 in endothelial cells
Bedenbender, K., Scheller, N., Fischer, S., Leiting, S., Preissner, K. T., Schmeck, B., & Vollmeister, E. (2019) · The FASEB Journal · doi:10.1096/fj.201900451r · Cited by 28
Toward isozyme-selective inhibitors of histone deacetylase as therapeutic agents for the treatment of cancer
Ononye, S. N., van Heyst, M., Falcone, E. M., Anderson, A., & Wright, D. (2012) · Pharmaceutical Patent Analyst · doi:10.4155/ppa.12.21 · Cited by 28
Mechanism of Action of 2-Aminobenzamide HDAC Inhibitors in Reversing Gene Silencing in Friedreich’s Ataxia
Soragni, E., Chou, C. J., Rusche, J. R., & Gottesfeld, J. M. (2015) · Frontiers in Neurology · doi:10.3389/fneur.2015.00044 · Cited by 30
SUV39H1/H3K9me3 attenuates sulforaphane-induced apoptotic signaling in PC3 prostate cancer cells
Watson, G. W., Wickramasekara, S. I., Palomera‐Sánchez, Z., Black, C., Maier, C. S., Williams, D. E., Dashwood, R. H., & Ho, E. (2014) · Oncogenesis · doi:10.1038/oncsis.2014.47 · Cited by 28
Targeted Gene Repression Using Novel Bifunctional Molecules to Harness Endogenous Histone Deacetylation Activity
Butler, K. V., Chiarella, A. M., Jin, J. J., & Hathaway, N. A. (2017) · ACS Synthetic Biology · doi:10.1021/acssynbio.7b00295 · Cited by 31
Proteomic Analysis of Cellular Systems
Hein, M. Y., Sharma, K., Cox, J., & Mann, M. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-385944-0.00001-0 · Cited by 30
Romidepsin
Yang, L. P. H. (2011) · Drugs · doi:10.2165/11207170-000000000-00000 · Cited by 28
Synthesis and biological evaluation of santacruzamate A analogues for anti-proliferative and immunomodulatory activity
Gromek, S. M., deMayo, J. A., Maxwell, A. T., West, A. M., Pavlik, C. M., Zhao, Z., Li, J., Wiemer, A. J., Zweifach, A., & Balunas, M. J. (2016) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2016.08.040 · Cited by 28
Kinetic Tuning of HDAC Inhibitors Affords Potent Inducers of Progranulin Expression
Moreno-Yruela, C., Fass, D. M., Cheng, C., Herz, J., Olsen, C. A., & Haggarty, S. J. (2019) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.9b00281 · Cited by 27
Screening for Compounds That Modulate Epigenetic Regulation of the Transcriptome: An Overview
Eglen, R. M., & Reisine, T. (2011) · SLAS DISCOVERY · doi:10.1177/1087057111417871 · Cited by 28
Rapid degradation of histone deacetylase 1 (HDAC1) reveals essential roles in both gene repression and active transcription
English, D. M., Lee, S. N., Sabat, K. A., Baker, I. M., Pham, T. K., Collins, M. O., & Cowley, S. M. (2024) · Nucleic Acids Research · doi:10.1093/nar/gkae1223 · Cited by 27
Chemoproteomics Demonstrates Target Engagement and Exquisite Selectivity of the Clinical Phosphodiesterase 10A Inhibitor MP-10 in Its Native Environment
Schülke, J.-P., McAllister, L. A., Geoghegan, K. F., Parikh, V. D., Chappie, T. A., Verhoest, P. R., Schmidt, C. J., Johnson, D. S., & Brandon, N. J. (2014) · ACS Chemical Biology · doi:10.1021/cb500671j · Cited by 26
Cyclic Tetrapeptide HDAC Inhibitors with Improved Plasmodium falciparum Selectivity and Killing Profile
Collins, J. E., Lee, J. W., Bohmer, M. J., Welden, J. D., Arshadi, A. K., Du, L., Cichewicz, R. H., & Chakrabarti, D. (2021) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.1c00341 · Cited by 26
Bufexamac ameliorates LPS-induced acute lung injury in mice by targeting LTA4H
Xiao, Q., Dong, N., Yao, X., Wu, D., Lu, Y., Mao, F., Zhu, J., Li, J., Huang, J. Y., Chen, A., et al. (2016) · Scientific Reports · doi:10.1038/srep25298 · Cited by 26
A SILAC-Based Method for Quantitative Proteomic Analysis of Intestinal Organoids
Gonneaud, A., Jones, C. M., Turgeon, N., Lévesque, D., Asselin, C., Boudreau, F., & Boisvert, F. (2016) · Scientific Reports · doi:10.1038/srep38195 · Cited by 26
Conversion of a Single Polypharmacological Agent into Selective Bivalent Inhibitors of Intracellular Kinase Activity
Gower, C. M., Thomas, J. R., Harrington, E. M., Murphy, J., Chang, M. E. K., Cornella‐Taracido, I., Jain, R. K., Schirle, M., & Maly, D. J. (2015) · ACS Chemical Biology · doi:10.1021/acschembio.5b00847 · Cited by 26
Histone deacetylases inhibitors: conjugation to other anti-tumour pharmacophores provides novel tools for cancer treatment
Papavassiliou, K. A., & Papavassiliou, A. G. (2013) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2014.857401 · Cited by 26
Discovery of a Highly Potent and Selective HDAC8 Degrader: Advancing the Functional Understanding and Therapeutic Potential of HDAC8
Xiao, Y., Awasthee, N., Liu, Y., Meng, C., He, M. Y., Hale, S. M., Karki, R., Lin, Z., Mosterio, M., Garcia, B. A., et al. (2024) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.4c00761 · Cited by 24
Mass spectrometry approaches to monitor protein–drug interactions
Zinn, N., Hopf, C., Drewes, G., & Bantscheff, M. (2012) · Methods · doi:10.1016/j.ymeth.2012.05.008 · Cited by 25
Self-citation
Epigenetic mechanisms within the cingulate cortex regulate innate anxiety-like behavior
Sah, A., Sotnikov, S., Kharitonova, M., Schmuckermair, C., Diepold, R. P., Landgraf, R., Whittle, N., & Singewald, N. (2019) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyz004 · Cited by 24
Profiling the interactome of oligonucleotide drugs by proximity biotinylation
Hanswillemenke, A., Hofacker, D. T., Sorgenfrei, M., Fruhner, C., Franz‐Wachtel, M., Schwarzer, D., Maček, B., & Stafforst, T. (2024) · Nature Chemical Biology · doi:10.1038/s41589-023-01530-z · Cited by 24
Valproic acid enhances fludarabine-induced apoptosis mediated by ROS and involving decreased AKT and ATM activation in B-cell-lymphoid neoplastic cells
Yoon, J., Ishdorj, G., Graham, B. A., Johnston, J. B., & Gibson, S. B. (2013) · APOPTOSIS · doi:10.1007/s10495-013-0906-7 · Cited by 24
Metastasis suppression by BRMS1 associated with SIN3 chromatin remodeling complexes
Hurst, D. R. (2012) · Cancer and Metastasis Reviews · doi:10.1007/s10555-012-9363-y · Cited by 24
Perspectives on the Discovery of Small-Molecule Modulators for Epigenetic Processes
Lu, Q., Quinn, A. M., Patel, M. P., Semus, S. F., Graves, A. P., Bandyopadhyay, D., Pope, A. J., & Thrall, S. H. (2012) · SLAS DISCOVERY · doi:10.1177/1087057112437763 · Cited by 24
Histone deacetylases differentially regulate the proliferative phenotype of mouse bone marrow stromal and hematopoietic stem/progenitor cells
Dhoke, N. R., Kalabathula, E., Kaushik, K., Geesala, R., Sravani, B., & Das, A. (2016) · Stem Cell Research · doi:10.1016/j.scr.2016.07.001 · Cited by 24
Identification of genes directly responding to DLK1 signaling in Callipyge sheep
Yu, H. M., Waddell, J. N., Kuang, S., Tellam, R. L., Cockett, N., & Bidwell, C. A. (2018) · BMC Genomics · doi:10.1186/s12864-018-4682-1 · Cited by 24
Molecular mechanisms of bleeding disorderassociated GFI1B Q287* mutation and its affected pathways in megakaryocytes and platelets
van Oorschot, R., Hansen, M., Koornneef, J. M., Marneth, A. E., Bergevoet, S. M., van Bergen, M. G. J. M., van Alphen, F. P. J., van der Zwaan, C., Martens, J. H. A., Vermeulen, M., et al. (2019) · Haematologica · doi:10.3324/haematol.2018.194555 · Cited by 28
Qualitative and Quantitative Protein Complex Prediction Through Proteome-Wide Simulations
Rizzetto, S., Priami, C., & Csikász‐Nagy, A. (2015) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1004424 · Cited by 23
Novel Antitubercular 6-Dialkylaminopyrimidine Carboxamides from Phenotypic Whole-Cell High Throughput Screening of a SoftFocus Library: Structure–Activity Relationship and Target Identification Studies
Wilson, C. R., Gessner, R. K., Moosa, A., Seldon, R., Warner, D. F., Mizrahi, V., de Melo, C. S., Simelane, S. B., Nchinda, A. T., Abay, E. T., et al. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b01347 · Cited by 23
Self-citation
MIER3 induces epithelial-mesenchymal transition and promotes breast cancer cell aggressiveness via forming a co-repressor complex with HDAC1/HDAC2/Snail
Huang, W.-Q., Chen, J., Liu, X., Liu, X., Duan, S., Chen, L., Liu, X., Lan, J., Zou, Y., Guo, D., et al. (2021) · Experimental Cell Research · doi:10.1016/j.yexcr.2021.112722 · Cited by 23
Modular transcriptional repertoire and MicroRNA target analyses characterize genomic dysregulation in the thymus of Down syndrome infants
Moreira‐Filho, C. A., Bando, S. Y., Bertonha, F. B., Silva, F. N., Costa, L. D. F., Ferreira, L., Furlanetto, G., Chaccur, P., Zerbini, M. C. N., & Carneiro-Sampaio, M. M. S. (2016) · Oncotarget · doi:10.18632/oncotarget.7120 · Cited by 23
A Substrate-Independent TR-FRET Histone Deacetylase Inhibitor Assay
Marks, B. D., Fakhoury, S. A., Frazee, W. J., Eliason, H. C., & Riddle, S. M. (2011) · SLAS DISCOVERY · doi:10.1177/1087057111422102 · Cited by 23
Aspirin inhibits proteasomal degradation and promotes α-synuclein aggregate clearance through K63 ubiquitination
Gao, J., Liu, Y., Si, C., Guo, R. H., Hou, S., Liu, X., Long, H., Liu, D., Xu, D., Zhang, Z.-R., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-56737-6 · Cited by 22
Evidence that HDAC7 acts as an epigenetic “reader” of AR acetylation through NCoR-HDAC3 dissociation
Zhang, Y., Andrade, R. E., Hanna, A. A., & Pflum, M. K. H. (2022) · Cell chemical biology · doi:10.1016/j.chembiol.2022.05.008 · Cited by 22
Role of Histone Deacetylases in T-Cell Development and Function
Pieniawska, M., & Iżykowska, K. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23147828 · Cited by 24
New Affinity Probe Targeting VEGF Receptors for Kinase Inhibitor Selectivity Profiling by Chemical Proteomics
Ku, X., Heinzlmeir, S., Helm, D., Médard, G., & Küster, B. (2014) · Journal of Proteome Research · doi:10.1021/pr401247t · Cited by 22
Synergistic apoptotic response between valproic acid and fludarabine in chronic lymphocytic leukaemia (CLL) cells involves the lysosomal protease cathepsin B
Yoon, J.-Y., Szwajcer, D., Ishdorj, G., Benjaminson, P., Xiao, W., Kumar, R., Johnston, J. B., & Gibson, S. B. (2013) · Blood Cancer Journal · doi:10.1038/bcj.2013.50 · Cited by 22
Promises and challenges of anticancer drugs that target the epigenome
Verbrugge, I., Johnstone, R. W., & Bots, M. L. (2011) · Epigenomics · doi:10.2217/epi.11.82 · Cited by 22
CDK12 inhibition reduces abnormalities in cells from patients with myotonic dystrophy and in a mouse model
Ketley, A., Wojciechowska, M., Ghidelli, S., Bamborough, P., Ghosh, T. K., López-Morató, M., Sedehizadeh, S., Malik, N. A., Tang, Z., Powalowska, P. K., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aaz2415 · Cited by 22
Self-citation
Chromatin context-dependent effects of epigenetic drugs on CRISPR-Cas9 editing
Schep, R., Trauernicht, M., Vergara, X., Friskes, A., Morris, B., Gregoricchio, S., Manzo, S. G., Zwart, W. T., Beijersbergen, R. L., Medema, R. H., et al. (2024) · Nucleic Acids Research · doi:10.1093/nar/gkae570 · Cited by 21
First Fluorescent Acetylspermidine Deacetylation Assay for HDAC10 Identifies Selective Inhibitors with Cellular Target Engagement**
Herp, D., Ridinger, J., Robaa, D., Shinsky, S. A., Schmidtkunz, K., Yesiloglu, T. Z., Bayer, T., Steimbach, R. R., Herbst‐Gervasoni, C. J., Merz, A., et al. (2022) · ChemBioChem · doi:10.1002/cbic.202200180 · Cited by 22
Decrypting lysine deacetylase inhibitor action and protein modifications by dose-resolved proteomics
Chang, Y.-C., Gnann, C., Steimbach, R. R., Bayer, F. P., Lechner, S., Sakhteman, A., Abele, M., Zecha, J., Trendel, J., The, M., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114272 · Cited by 25
Class I Lysine Deacetylases Facilitate Glucocorticoid-induced Transcription*
Kadiyala, V., Patrick, N. M., Mathieu, W., Jaime-Frias, R., Pookhao, N., An, L.-L., & Smith, C. L. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.505115 · Cited by 24
SAHA Capture Compound – A novel tool for the profiling of histone deacetylases and the identification of additional vorinostat binders
Fischer, J. J., Michaelis, S., Schrey, A. K., Diehl, A., Graebner, O. Y., Ungewiss, J., Horzowski, S., Glinski, M., Kroll, F. K., Dreger, M., et al. (2011) · PROTEOMICS · doi:10.1002/pmic.201000717 · Cited by 21
Dynamic Histone Acetylation of H3K4me3 Nucleosome Regulates MCL1 Pre‐mRNA Splicing
Khan, D. H., Gonzalez, C., Tailor, N., Hamedani, M. K., Leygue, E., & Davie, J. (2016) · Journal of Cellular Physiology · doi:10.1002/jcp.25337 · Cited by 22
Stress-Activated Kinase Mitogen-Activated Kinase Kinase-7 Governs Epigenetics of Cardiac Repolarization for Arrhythmia Prevention
Chowdhury, S. K., Liu, W., Zi, M., Li, Y., Wang, S., Tsui, H., Prehar, S., Castro, S. J., Zhang, H., Ji, Y. I., et al. (2016) · Circulation · doi:10.1161/circulationaha.116.022941 · Cited by 21
A Common Mechanism Links Activities of Butyrate in the Colon
Verma, M. S., Fink, M. J., Salmon, G. L., Fornelos, N., Ohara, T. E., Ryu, H., Vlamakis, H. C., Xavier, R. J., Stappenbeck, T. S., & Whitesides, G. M. (2018) · ACS Chemical Biology · doi:10.1021/acschembio.8b00073 · Cited by 22
Pharmacophore-based virtual screening for identification of potential selective inhibitors of human histone deacetylase 6
Uba, A. İ., & Yelekçi, K. (2018) · Computational Biology and Chemistry · doi:10.1016/j.compbiolchem.2018.10.016 · Cited by 22
HDAC6 Is Involved in the Histone Deacetylation of In Vitro Maturation Oocytes and the Reprogramming of Nuclear Transplantation in Pig
Sun, J., Liu, Q., Lv, L., RuYu, S., Li, Z. P., Huang, B., Cui, K., & Shi, D. (2021) · Reproductive Sciences · doi:10.1007/s43032-021-00533-2 · Cited by 21
The emerging field of chemo‐ and pharmacoproteomics
Hess, S. Y. (2012) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.201200091 · Cited by 20
The C-Terminal Putative Nuclear Localization Sequence of BReast cancer Metastasis Suppressor 1, BRMS1, Is Necessary for Metastasis Suppression
Hurst, D. R., Xie, Y., Thomas, J. W., Liu, J., Edmonds, M. D., Stewart, M. D., & Welch, D. R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055966 · Cited by 20
Methyl Effect in Azumamides Provides Insight Into Histone Deacetylase Inhibition by Macrocycles
Maolanon, A. R., Villadsen, J. S., Christensen, N. J., Hoeck, C. R., Friis, T., Harris, P., Gotfredsen, C. H., Fristrup, P., & Olsen, C. A. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm501399d · Cited by 20
Profiling of Substrates for Zinc‐dependent Lysine Deacylase Enzymes: HDAC3 Exhibits Decrotonylase Activity In Vitro
Madsen, A. S., & Olsen, C. A. (2012) · Angewandte Chemie · doi:10.1002/ange.201203754 · Cited by 20
Increasing the Throughput and Reproducibility of Activity-Based Proteome Profiling Studies with Hyperplexing and Intelligent Data Acquisition
Budayeva, H. G., Ma, T. P., Wang, S., Choi, M., & Rose, C. M. (2024) · Journal of Proteome Research · doi:10.1021/acs.jproteome.3c00598 · Cited by 19
An azumamide C analogue without the zinc-binding functionality
Villadsen, J. S., Kitir, B., Wich, K., Friis, T., Madsen, A. S., & Olsen, C. A. (2014) · MedChemComm · doi:10.1039/c4md00252k · Cited by 19
Studying epigenetic complexes and their inhibitors with the proteomics toolbox
Weigt, D., Hopf, C., & Médard, G. (2016) · Clinical Epigenetics · doi:10.1186/s13148-016-0244-z · Cited by 18
Self-citation
Critical role of deoxynucleotidyl transferase terminal interacting protein 1 in oral cancer
Sawai, Y., Kasamatsu, A., Nakashima, D., Fushimi, K., Kasama, H., Iyoda, M., Kouzu, Y., Shiiba, M., Tanzawa, H., & Uzawa, K. (2018) · Laboratory Investigation · doi:10.1038/s41374-018-0070-3 · Cited by 19
MiR-520d-5p modulates chondrogenesis and chondrocyte metabolism through targeting HDAC1
Lu, J., Zhou, Z., Sun, B., Han, B., Fu, Q., Han, Y., Yuan, W., Xu, Z., & Chen, A. (2020) · Aging · doi:10.18632/aging.103831 · Cited by 19
Molecular Epigenetics: Chemical Biology Tools Come of Age
Bagert, J. D., & Muir, T. W. (2021) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-080120-021109 · Cited by 21
Slow-Binding and Covalent HDAC Inhibition: A New Paradigm?
Raouf, Y. S., & Moreno–Yruela, C. (2024) · JACS Au · doi:10.1021/jacsau.4c00828 · Cited by 19
The Effects of Histone Deacetylase Inhibition on the Levels of Cerebral Cytokines in an Animal Model of Mania Induced by Dextroamphetamine
Valvassori, S. S., Resende, W. R., Varela, R. B., Arent, C. O., Gava, F. F., Peterle, B. R., Dal-Pont, G. C., Carvalho, A. F., Andersen, M. L., & Quevedo, J. (2018) · Molecular Neurobiology · doi:10.1007/s12035-017-0384-y · Cited by 18
Supramolecularly self-assembled nano-twin drug for reversing multidrug resistance
Wu, C., Li, X., Shi, L., Gao, X., Li, J., Zhu, X., & Zhang, C. (2018) · Biomaterials Science · doi:10.1039/c8bm00437d · Cited by 18
LncRNA SOX1‐OT V1 acts as a decoy of HDAC10 to promote SOX1‐dependent hESC neuronal differentiation
Xi, J., Xu, Y., Guo, Z., Li, J., Wu, Y., Sun, Q., Wang, Y., Chen, M., Zhu, S., Bian, S., et al. (2021) · EMBO Reports · doi:10.15252/embr.202153015 · Cited by 20
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing
Shen, M., Asawa, R. R., Zhang, Y., Cunningham, E. A., Sun, H., Tropsha, A., Janzen, W. P., Muratov, E. N., Capuzzi, S. J., Farag, S., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.23462 · Cited by 18
A potential histone-chaperone activity for the MIER1 histone deacetylase complex
Wang, S., Fairall, L., Pham, T. K., Ragan, T. J., Vashi, D., Collins, M. O., Dominguez, C., & Schwabe, J. W. R. (2023) · Nucleic Acids Research · doi:10.1093/nar/gkad294 · Cited by 20
Conditional lethality profiling reveals anticancer mechanisms of action and drug-nutrient interactions
Flickinger, K. M., Wilson, K. M., Rossiter, N. J., Hunger, A. L., Vishwasrao, P., Lee, T. D., Fritz, C. M., Richards, R. M., Hall, M. D., & Cantor, J. R. (2024) · Science Advances · doi:10.1126/sciadv.adq3591 · Cited by 18
A Functional Proteomics Perspective of DBC1 as a Regulator of Transcription.
Joshi, P., Quach, O. L., Giguère, S., & Cristea, I. M. (2013) · PubMed · Cited by 17
Quantitative Chemical Proteomics Identifies Novel Targets of the Anti-cancer Multi-kinase Inhibitor E-3810
Colzani, M., Noberini, R., Romanenghi, M., Colella, G., Pasi, M., Fancelli, D., Varasi, M., Minucci, S., & Bonaldi, T. (2014) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m113.034173 · Cited by 17
Chaperone co-inducer BGP-15 inhibits histone deacetylases and enhances the heat shock response through increased chromatin accessibility
Budzyński, M. A., Crul, T., Himanen, S. V., Tóth, N., Ötvös, F., Sistonen, L., & Vı́gh, L. (2017) · Cell Stress and Chaperones · doi:10.1007/s12192-017-0798-5 · Cited by 17
Metastasis-Associated Protein 2 Represses NF-κB to Reduce Lung Tumor Growth and Inflammation
El-Nikhely, N. A., Karger, A., Sarode, P., Singh, I., Weigert, A., Wietelmann, A., Stiewe, T., Dammann, R., Fink, L., Grimminger, F., et al. (2020) · Cancer Research · doi:10.1158/0008-5472.can-20-1158 · Cited by 17
Screening and profiling assays for HDACs and sirtuins
Howitz, K. T. (2015) · Drug Discovery Today Technologies · doi:10.1016/j.ddtec.2015.10.008 · Cited by 17
Epigenetic Silencing of BMP6 by the SIN3A–HDAC1/2 Repressor Complex Drives Melanoma Metastasis via FAM83G/PAWS1
Min, D., Byun, J., Lee, E.-J., Khan, A. A., Liu, C., Loudig, O. D., Hu, W., Zhao, Y., Herlyn, M., Tycko, B., et al. (2021) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-21-0289 · Cited by 18
TdIF1-LSD1 Axis Regulates Epithelial—Mesenchymal Transition and Metastasis via Histone Demethylation of E-Cadherin Promoter in Lung Cancer
Liu, Q., Xiong, J., Xu, D., Hao, N., Zhang, Y., Sang, Y., Wang, Z., Zheng, X., Min, J., Diao, H., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms23010250 · Cited by 17
GEMC1 and MCIDAS interactions with SWI/SNF complexes regulate the multiciliated cell-specific transcriptional program
Lewis, M., Terré, B., Knobel, P. A., Cheng, T., Lu, H., Attolini, C. S., Smak, J., Coyaud, É., Garcı́a-Cao, I., Sharma, S., et al. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-05720-4 · Cited by 16
A review of the therapeutic potential of histone deacetylase inhibitors in rhabdomyosarcoma
Selim, O. A., Song, C. H., Kumar, A. E., Phelan, R., Singh, A. S., & Federman, N. C. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1244035 · Cited by 16
Histone deacetylase inhibitors for the treatment of cancer stem cells
Dvořáková, M., & Vaněk, T. (2016) · MedChemComm · doi:10.1039/c6md00297h · Cited by 16
Chemoprobe-based assays of histone lysine demethylase 1A target occupation enable in vivo pharmacokinetics and pharmacodynamics studies of KDM1A inhibitors
Mascaró, C., Ortega, A., Carceller, E., Rodriguez, R. R., Ciceri, F., Lunardi, S., Li, Y., Hilbert, M., & Maes, T. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.006980 · Cited by 16
Dabigatran and Dabigatran Ethyl Ester: Potent Inhibitors of Ribosyldihydronicotinamide Dehydrogenase (NQO2)
Michaelis, S., Marais, A., Schrey, A. K., Graebner, O. Y., Schaudt, C., Sefkow, M., Kroll, F. K., Dreger, M., Glinski, M., KOESTER, H., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm3001339 · Cited by 16
Regulation of Histone Deacetylases by MicroRNAs in Bone
Shreya, S., Malavika, D., Priya, V. R., & Selvamurugan, N. (2018) · Current Protein and Peptide Science · doi:10.2174/1389203720666181031143129 · Cited by 16
Proteomic analysis identifies ZMYM2 as endogenous binding partner of TBX18 protein in 293 and A549 cells
Lüdtke, T. H., Kleppa, M., Rivera‐Reyes, R., Qasrawi, F., Connaughton, D. M., Shril, S., Hildebrandt, F., & Kispert, A. (2021) · Biochemical Journal · doi:10.1042/bcj20210642 · Cited by 15
Chemoproteomic profiling to identify activity changes and functional inhibitors of DNA-binding proteins
Ruprecht, B., Wei, L., Zheng, L., Bodea, S., Mo, X., Maschberger, M., Stoehr, G., Hahne, H., Cornella‐Taracido, I., & Chi, A. (2022) · Cell chemical biology · doi:10.1016/j.chembiol.2022.10.008 · Cited by 17
Nuclear Localization of the Transcriptional Regulator MIER1α Requires Interaction with HDAC1/2 in Breast Cancer Cells
Li, S., Paterno, G. D., & Gillespie, L. L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0084046 · Cited by 15
Thermodynamics of Binding of Structurally Similar Ligands to Histone Deacetylase 8 Sheds Light on Challenges in the Rational Design of Potent and Isozyme-Selective Inhibitors of the Enzyme
Singh, P., Suzuki, T., Mandal, T., Balsubramanian, N., Haldar, M., Mueller, D. J., Strode, J. A., Cook, G. R., Mallik, S., & Srivastava, D. K. (2014) · Biochemistry · doi:10.1021/bi500711x · Cited by 16

Authors: Bantscheff, M., Hopf, C., Savitski, M. M., Dittmann, A., Grandi, P., Michon, A.-M., Schlegl, J., Abraham, Y., Becher, I., Bergamini, G., Boesche, M., Delling, M., Dümpelfeld, B., Eberhard, D., Huthmacher, C., Mathieson, T., Poeckel, D., Reader, V., Strunk, K., Sweetman, G., Kruse, U., Neubauer, G., Ramsden, N. G., & Drewes, G.
Corresponding author: Bantscheff, Marcus
Drewes, Gerard
ORCID: Bantscheff, Marcus
Hopf, Carsten
Savitski, Mikhail M
Dittmann, Antje
Grandi, Paola
Schlegl, Judith
Abraham, Yann
Becher, Isabelle
Bergamini, Giovanna
Eberhard, Dirk
Mathieson, Toby
Reader, Valérie
Sweetman, Gavain
Neubauer, Gitte
Ramsden, Nigel G
Drewes, Gerard
Venue: Nature Biotechnology
Publisher: Springer Science and Business Media LLC
Published: 2011-01-23
Volume: 29
Issue: 3
Pages: 255-265
ISSN: 0733-222X (ISSN-L)
1087-0156
1546-1696
DOI: 10.1038/nbt.1759
OpenAlex: W2007139310
Cited by: 659
References: 50
Citations by year: 2026: 15 · 2025: 32 · 2024: 25 · 2023: 33 · 2022: 40 · 2021: 37 · 2020: 33 · 2019: 37 · 2018: 33 · 2017: 46 · 2016: 69 · 2015: 68 · 2014: 54 · 2013: 58 · 2012: 49
FWCI: 24.95
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
Locations: Nature Biotechnology (publishedVersion)
PubMed (publishedVersion)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Histone Deacetylase Inhibitors Research
Physical Sciences › Chemistry › Spectroscopy › Advanced Proteomics Techniques and Applications
Physical Sciences › Chemistry › Spectroscopy › Mass Spectrometry Techniques and Applications
Keywords: histone deacetylase inhibitors, chemoproteomics, hydroxamate inhibitors, bufexamac, HDAC6, HDAC10, drug selectivity, affinity capture
MeSH terms: Histone Deacetylases, Peptide Mapping, Mass Spectrometry, Protein Interaction Mapping, Proteomics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Chemoproteomics profiling of HDAC inhibitors reveals selective targeting of HDAC complexes

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks